Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease
Year: 2021
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Ageing Research Reviews
Institutions: National Institutes of Health, National Institute on Aging
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3146410983
